Brand profile · Biotechnology Research

CHITOSE Group

Singapore-based CHITOSE Group operates in Biotechnology Research. It is privately held, and its site is chitose-bio.com. It holds four addresses on record across two office countries. Headcount on record is 62. Its work is tagged agriculture, biotechnology and agribusiness. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Series unknown, US$28.5M. It is listed alongside six similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2005 1 entity UEN 2 office countries US$ 28.5M Series unknown
Registry verified · ACRA

Key facts

Counted staff
62
self-reported band not used
Founded
2005
21 years
Legal entities
1
ACRA
Office countries
2
4 addresses
Funding rounds
3
Series unknown · Apr 2025 · US$ 28.5M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

CHITOSE Group: 1 registry entityCHITOSE Group is linked to 1 registry entity: CHITOSE SINGAPORE PTE LTD (UEN 199101498D, confirmed).CHITOSE GroupCHITOSE SINGAPORE PTELTDUEN 199101498DConfirmed · ACRA
Show as table · CHITOSE Group: 1 registry entity
CHITOSE Group: 1 registry entity
CHITOSE SINGAPORE PTE LTDUEN 199101498D
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

CHITOSE Group is a family of biotechnology companies leading the global bioeconomy. Our vision is to enable humanity to live in abundance for the next millennium by harnessing the power of living things. Through both technological innovation and business development, we collaborate with partners worldwide to unlock the potential of biotechnology.

MATSURI INITIATIVE MATSURI began in 2021 with the goal of building a microalgae industry. From 2025 onward, it has evolved beyond microalgae, transforming into a cross-industry initiative that drives the bioeconomy, striving to build a bio-based society. https://matsuri-partners.chitose-bio.com/en

STABLE CELL LINE DEVELOPMENT SERVICE Chitose Laboratory accelerates biopharmaceutical development and reduces costs using its high-performance CHO-MK cells to support global healthcare.

https://chitose-bio.com/cld-service

AI x BIOMANUFACTURING Chitose Laboratory is developing a bio-production management system that achieves advanced culture control beyond human capability. By integrating sensing technologies that convert subtle changes into measurable data with AI-driven prediction and optimization, we are realizing a new frontier of biomanufacturing. https://chitose-bio.com/jp/ai-bioproduction (Japanese)

CHITOSE AGRICULTURE Chitose Agriculture promotes sustainable farming that provides tasty crops for a thousand years by emphasizing a healthy soil environment.

https://agriculture.chitose-bio.com/en

Specialties

All 7 specialties
  • biomanufacturing
  • biotechnology
  • bio-industry
  • algae
  • microalgae
  • agriculture
  • agribusiness

Related specialties

Locations

2
Countries with an office address4 addresses on record

Country footprint

Offices in 2 countriesCountry footprint: 2 countries, primary SG. Codes: SG, JP.2 countriesprimary SGSGJP
Show as table · Offices in 2 countries
Offices in 2 countries
Countries2
Primary countrySG

All codes: SG JP

Addresses

  • JPSakado; Takatsu-ku; Kawasaki, Kanagawa 2130012
  • SGEu Tong Sen Street; 10-12 The Central; Singapore, 059817Primary
  • JP2-13-3, Nogawahoncho, Miyamae-ku; Kawasaki, Kanagawa 216-0041
  • JPYoshida-Honmachi; Maskawa Building for Education and Research, Kitabu Campus; Sakyo-ku, Kyoto-shi, , Kyoto 606-8224

Grid intelligence Members

Funding

Last round · 10 April 2025US$ 28.5MSeries unknown
Rounds3
Round typeSeries unknown · venture round
Amount (USD)28,500,000
Stage ranknot recorded
Investors named0
Since last round9 mo

Funding

3 funding roundsFunding timeline. Latest round 10 Apr 2025: Series unknown, US$ 28.5M.20052026Series unknownUS$ 28.5M3 rounds
Show as table · 3 funding rounds
3 funding rounds
Rounds3
Axis2005 to 2026
Series unknown · 10 Apr 2025US$ 28.5M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under CHITOSE Group?

One Singapore entity on ACRA: CHITOSE SINGAPORE PTE LTD (UEN 199101498D), high confidence.

How many people work at CHITOSE Group?

62 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does CHITOSE Group have offices?

4 addresses on record.

Has CHITOSE Group raised funding?

Three rounds. Latest 10 April 2025: Series unknown, US$28,500,000.

What does CHITOSE Group list as its specialties?

Seven tags on the brand's own list, among them agriculture, biotechnology and agribusiness.

Which companies are listed alongside CHITOSE Group?

6 profiles list CHITOSE Group as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. Cellivate Technologies and TA Vital list it back.

What is CHITOSE Group's website?